Brazil's President Bolsonaro rejects purchase of coronavirus vaccine from China

▴ Brazil's President Bolsonaro rejects purchase of coronavirus vaccine from China
Brazil President said that he would not allow the Brazilan people to be anyone’s ‘guinea pig

Brazil’s President Jair Bolsonaro has decided on Wednesday to cancel the purchase of Coronavac, a COVID-19 vaccine in phase-3 clinical trials by Chinese firm Sinovac.

A day before, on Tuesday, Health Minister Eduardo Pazuello had confirmed that Brazil would buy the vaccine developed by Sinovac to include it in the immunization program, in addition to one developed by the UK-based AstraZeneca and Oxford University.

Bolsonaro said on social media, For sure, we will not buy the Chinese vaccine, because it is unjustifiable to pay billions for a vaccine that has not been through its testing phase. He also said that it would be a betrayal to buy Chinese vaccine.

The President also said that he would not allow the Brazilan people to be anyone’s ‘guinea pig’. Both Brazil President and Health Minister have been infected by a novel coronavirus.

Brazil has been among the world’s hardest-hit nations by the pandemic, with more than 5 million infections and more than 150,000 COVID-19 deaths. Earlier, Bangladesh had rejected co-financing of the phase 3 trial of the Sinovac made Corona vaccine.

back at home, India trend of steadily decreasing active cases continues unabated. The Active Cases have been sustained below 10% of the total cases for the last three days suggesting only 1 in 10 cases are active COVID19 patients across the country. Presently the active cases comprise merely 9.29% of the total positive cases of the country standing at 7,15,812. Registering another milestone, the daily Positivity Rate has also been maintained to less than 5% over the past three days. Yesterday, the daily Positivity Rate is reported to be 3.8%. The decrease in the daily positivity rate is simultaneously mapped by the falling active cases, which continue to be under 7.5L today (7,15,812).

The total recovered cases are close to 69 lakhs (68,74,518). The difference between active cases and recovered cases is consistently increasing and stands at 61,58,706 today.79,415 patients have recovered and discharged in the last 24 hours whereas the new confirmed cases are 55,839. The national Recovery Rate has progressed to 89.20%.81% of the new recovered cases are observed to be concentrated in 10 States/UTs.Maharashtra has contributed more than 23,000 to the single-day recovery.55,839 new confirmed cases were recorded during the last 24 hours.78% of these are from 10 States and UTs. Maharashtra and Kerala are still reporting a very high number of new cases with more than 8,000 cases each followed by Karnataka with more than 5,000 cases.702 case fatalities have been reported in the past 24 hours. Of these, nearly 82% are concentrated in ten States/UTs.More than 25% of new fatalities reported are from Maharashtra (180 deaths)

Tags : #Brazil #PresidentJairBolsonaro #LatestCOVIDNews23rdOct #Sinovac #Bangladesh #COVID19Vaccine #China

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026